Literature DB >> 23677994

Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1).

Chao Dai1, Dingding Shi, Wei Gu.   

Abstract

Numerous studies indicate the importance of acetylation in p53-mediated stress responses upon DNA damage. We and others previously showed that TIP60 (Tat-interacting protein of 60 kDa)-mediated acetylation of p53 at K120 is crucial for p53-dependent apoptotic responses. Nevertheless, it remains unclear how TIP60-mediated effects on p53 are dynamically regulated in vivo. Here, we report that UHRF1 (ubiquitin-like with PHD and RING finger domains 1) interacts with TIP60 both in vitro and in vivo and induces degradation-independent ubiquitination of TIP60. Moreover, UHRF1 expression markedly suppresses the ability of TIP60 to acetylate p53. In contrast, RNAi-mediated knockdown of UHRF1 increases the endogenous levels of p53 acetylation at K120 and p53-mediated apoptosis is significantly enhanced in UHRF1-depleted cells. To elucidate the mechanisms of this regulation, we found that the interaction between TIP60 and p53 is severely inhibited in the presence of UHRF1, suggesting that UHRF1 modulates TIP60-mediated functions in both K120 acetylation-dependent and -independent manners. Consistent with this notion, UHRF1 knockdown promotes activation of p21 and PUMA but not MDM2. These findings demonstrate that UHRF1 is a critical negative regulator of TIP60 and suggest that UHRF1-mediated effects on p53 may contribute, at least in part, to its role in tumorigenesis.

Entities:  

Keywords:  Acetylation; Apoptosis; Growth Arrest; Oncogene; TIP60; Tumor Suppressor Gene; UHRF1; Ubiquitination; p53

Mesh:

Substances:

Year:  2013        PMID: 23677994      PMCID: PMC3707659          DOI: 10.1074/jbc.M113.476606

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.

Authors:  Tatjana Crnogorac-Jurcevic; Rathi Gangeswaran; Vipul Bhakta; Gabriele Capurso; Samuel Lattimore; Masanori Akada; Makoto Sunamura; Wendy Prime; Fiona Campbell; Teresa A Brentnall; Eithne Costello; John Neoptolemos; Nicholas R Lemoine
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

2.  Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis.

Authors:  Sueli M Oba-Shinjo; Mario H Bengtson; Sheila M B Winnischofer; Christian Colin; Cleber G Vedoy; Zizi de Mendonça; Suely K N Marie; Mari C Sogayar
Journal:  Brain Res Mol Brain Res       Date:  2005-08-08

3.  Increased expression of DNA methyltransferase 1 (DNMT1) protein in uterine cervix squamous cell carcinoma and its precursor lesion.

Authors:  Morio Sawada; Yae Kanai; Eri Arai; Saori Ushijima; Hidenori Ojima; Setsuo Hirohashi
Journal:  Cancer Lett       Date:  2006-12-29       Impact factor: 8.679

4.  Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.

Authors:  Yi Tang; Jianyuan Luo; Wenzhu Zhang; Wei Gu
Journal:  Mol Cell       Date:  2006-12-28       Impact factor: 17.970

5.  Acetylation of the p53 DNA-binding domain regulates apoptosis induction.

Authors:  Stephen M Sykes; Hestia S Mellert; Marc A Holbert; Keqin Li; Ronen Marmorstein; William S Lane; Steven B McMahon
Journal:  Mol Cell       Date:  2006-12-28       Impact factor: 17.970

6.  Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth.

Authors:  Yonchu Jenkins; Vadim Markovtsov; Wayne Lang; Poonam Sharma; Denise Pearsall; Justin Warner; Christian Franci; Betty Huang; Jianing Huang; George C Yam; Joseph P Vistan; Erlina Pali; Jorge Vialard; Michel Janicot; James B Lorens; Donald G Payan; Yasumichi Hitoshi
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

7.  Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas.

Authors:  Dun-Fa Peng; Yae Kanai; Morio Sawada; Saori Ushijima; Nobuyoshi Hiraoka; Tomoo Kosuge; Setsuo Hirohashi
Journal:  Cancer Sci       Date:  2005-07       Impact factor: 6.716

8.  Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?

Authors:  Marianne Lorenzato; Stephanie Caudroy; Christian Bronner; Ghislaine Evrard; Maryline Simon; Anne Durlach; Philippe Birembaut; Christine Clavel
Journal:  Hum Pathol       Date:  2005-10       Impact factor: 3.466

9.  Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response.

Authors:  Chiara Gorrini; Massimo Squatrito; Chiara Luise; Nelofer Syed; Daniele Perna; Landon Wark; Francesca Martinato; Domenico Sardella; Alessandro Verrecchia; Samantha Bennett; Stefano Confalonieri; Matteo Cesaroni; Francesco Marchesi; Milena Gasco; Eugenio Scanziani; Maria Capra; Sabine Mai; Paolo Nuciforo; Tim Crook; John Lough; Bruno Amati
Journal:  Nature       Date:  2007-08-30       Impact factor: 49.962

10.  Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA.

Authors:  A Gupta; S Jha; D A Engel; D A Ornelles; A Dutta
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

View more
  17 in total

1.  Peli1 Modulates the Subcellular Localization and Activity of Mdmx.

Authors:  Dawei Li; Omid Tavana; Shao-Cong Sun; Wei Gu
Journal:  Cancer Res       Date:  2018-03-09       Impact factor: 12.701

Review 2.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

3.  Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53.

Authors:  Sara M Reed; Jussara Hagen; Van S Tompkins; Katie Thies; Frederick W Quelle; Dawn E Quelle
Journal:  Cell Cycle       Date:  2014-02-19       Impact factor: 4.534

Review 4.  The multi-functionality of UHRF1: epigenome maintenance and preservation of genome integrity.

Authors:  Monica Mancini; Elena Magnani; Filippo Macchi; Ian Marc Bonapace
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

5.  Auranofin Protects Intestine against Radiation Injury by Modulating p53/p21 Pathway and Radiosensitizes Human Colon Tumor.

Authors:  Dhrubajyoti Nag; Payel Bhanja; Randal Riha; Giselle Sanchez-Guerrero; Bruce F Kimler; Terance T Tsue; Chris Lominska; Subhrajit Saha
Journal:  Clin Cancer Res       Date:  2019-04-02       Impact factor: 13.801

Review 6.  p53 Acetylation: Regulation and Consequences.

Authors:  Sara M Reed; Dawn E Quelle
Journal:  Cancers (Basel)       Date:  2014-12-23       Impact factor: 6.639

7.  Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer.

Authors:  Jianjun Tang; Gang Wang; Meifang Zhang; Feng-yan Li; Yi Sang; Boqing Wang; Kaishun Hu; Yuanzhong Wu; Rongzhen Luo; Dan Liao; Jingying Cao; Xin Wang; Li Wang; Ruhua Zhang; Xiaoshi Zhang; Wu-guo Deng; Dan Xie; Rui-hua Xu; Tiebang Kang
Journal:  Oncotarget       Date:  2014-11-15

Review 8.  Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer.

Authors:  Mahmoud Alhosin; Ziad Omran; Mazin A Zamzami; Abdulrahman L Al-Malki; Hani Choudhry; Marc Mousli; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2016-11-14

9.  Interaction of the epigenetic integrator UHRF1 with the MYST domain of TIP60 inside the cell.

Authors:  Waseem Ashraf; Christian Bronner; Liliyana Zaayter; Tanveer Ahmad; Ludovic Richert; Mahmoud Alhosin; Abdulkhaleg Ibrahim; Ali Hamiche; Yves Mely; Marc Mousli
Journal:  J Exp Clin Cancer Res       Date:  2017-12-21

Review 10.  The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.

Authors:  Christian Bronner; Marc Mousli; Waseem Ashraf; Abdulkhaleg Ibrahim; Mahmoud Alhosin; Liliyana Zaayter; Khalid Ouararhni; Christophe Papin; Tanveer Ahmad; Ali Hamiche; Yves Mély
Journal:  Oncotarget       Date:  2017-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.